Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System. [electronic resource]
- Diabetes technology & therapeutics 05 2018
- 344-352 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't